INDICATIONS. KYPROLIS® (carfilzomib) is indicated in combination with dexamethasone or with lenalidomide plus dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy.
Carfilzomib (marketed under the trade name Kyprolis, developed by Onyx Pharmaceuticals) is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin.
Please contact at +91 9910645395 or send your enquiry at info@cancermedicinesnetwork to find the price of Kyprolis (Carfilzomib) for Injection in Vietnam, Philippines and Ireland. We take guarantee of quality and delivery as per the buyer’s requirements.
You can buy Kyprolis (Carfilzomib) from Verve Biosciences if the drug has not been approved or is not available in your country. We help patients and doctors get access to medicines at the lowest price worldwide. We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Verve Biosciences facilitates import of anti-cancer medicines Kyprolis (Carfilzomib) Send your enquiry to find the cost of Lucentis (Ranibizumab Injection) in China, UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.